TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-253 Cr | ₹319 Cr | ₹30 Cr | ₹-175 Cr | ₹-95 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-253 Cr |
| Mar2024 | ₹319 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹-175 Cr |
| Mar2021 | ₹-95 Cr |
How is Net Cash Inflow / Outflow of TORRENT PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-253 Cr | Negative | |
| Mar2024 | ₹319 Cr | 955.47 | |
| Mar2023 | ₹30 Cr | Positive | |
| Mar2022 | ₹-175 Cr | Negative | |
| Mar2021 | ₹-95 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹132,888.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
| MANKIND PHARMA | ₹86,802.6 Cr | -0.7% | -5.7% | -20.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -4% |
2.8% |
27.1% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses